Cambridge Investment Research Advisors’s ZYNGA INC. CL A COMMON ZNGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50,465
Closed -$466K 3281
2022
Q1
$466K Sell
50,465
-22,814
-31% -$200K ﹤0.01% 2164
2021
Q4
$469K Buy
73,279
+3,385
+5% +$23.4K ﹤0.01% 2155
2021
Q3
$526K Buy
69,894
+7,863
+13% +$71.4K ﹤0.01% 2011
2021
Q2
$659K Buy
62,031
+5,893
+10% +$62.1K ﹤0.01% 1842
2021
Q1
$573K Buy
56,138
+14,833
+36% +$155K ﹤0.01% 1805
2020
Q4
$408K Buy
41,305
+6,090
+17% +$54.8K ﹤0.01% 1911
2020
Q3
$321K Buy
35,215
+4,585
+15% +$42.7K ﹤0.01% 1889
2020
Q2
$292K Buy
30,630
+9,973
+48% +$81.8K ﹤0.01% 1905
2020
Q1
$142K Buy
20,657
+1,366
+7% +$8.98K ﹤0.01% 2035
2019
Q4
$118K Sell
19,291
-27,076
-58% -$167K ﹤0.01% 2298
2019
Q3
$270K Buy
46,367
+30,102
+185% +$181K ﹤0.01% 1906
2019
Q2
$100K Buy
+16,265
New +$95.8K ﹤0.01% 2101
2016
Q2
Sell
-482,271
Closed -$1.1M 1692
2016
Q1
$1.1M Buy
+482,271
New +$1.08M 0.02% 531

Other funds holding ZNGA

Cambridge Investment Research Advisors's ZNGA Position: Q2 2022 in Review

Cambridge Investment Research Advisors sold out of ZYNGA INC. CL A COMMON (ZNGA) in Q2 2022, closing a stake of 50,465 shares — an estimated $466K sold.

Cambridge Investment Research Advisors first reported a position in ZNGA in Q1 2016 and held it in 13 quarters. The position peaked at $1.1M in Q1 2016. 3 funds tracked by Wall St. Rank hold ZNGA as of Q2 2022.

  • Cambridge Investment Research Advisors reported no remaining ZYNGA INC. CL A COMMON position as of Q2 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 50,465 ZYNGA INC. CL A COMMON shares in Q2 2022, an estimated $466K.
  • Cambridge Investment Research Advisors first reported a position in ZYNGA INC. CL A COMMON in Q1 2016 and held it in 13 quarters.
  • Cambridge Investment Research Advisors's ZYNGA INC. CL A COMMON position peaked at $1.1M in Q1 2016.
  • 3 funds tracked by Wall St. Rank held ZYNGA INC. CL A COMMON as of Q2 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.